Trials / Sponsors / Rznomics, Inc.
Rznomics, Inc.
Academic / Other · 4 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 in Combination With Valganciclovir (VGCV) Hepatocellular Carcinoma (HCC) | Phase 1 / Phase 2 | 2024-12-18 |
| Recruiting | A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 With Valganciclovir (VGCV) in Subjects Wit Glioblastoma | Phase 1 / Phase 2 | 2024-10-08 |
| Active Not Recruiting | A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 with Valganciclovir (VGCV) in Subjects wit Hepatocellular Carcinoma | Phase 1 / Phase 2 | 2022-07-29 |
| Available | Expanded Access Program for GBM Subjects Glioblastoma | — | — |